The HDAC inhibitor romidepsin (FK228; depsipeptide) has also beendemonstrated to be effective against synovial sarcoma models, where nanomolarlevels cause histone acetylation, inhibition of growth, and invasion in cellcultures and mouse xenografts [16]. This evidence concerns the gene HDAC9 and synovial sarcoma.